Investigation of Therapeutic Potential of Phenolic Constituents of Pleurospermum candollei and Enzyme Inhibitory Activities by In Vitro and In Silico Approach

Le résumé fourni par la source

ABSTRACT Pleurospermum candollei (DC.) Benth. ex C.B.Clarke is a wild edible herb, known for its nutritional benefits and has been used in traditional medicines. To explore the bioactivities responsible for its beneficial effects, in this study, we analyzed the n ‐butanol fraction of P. candollei for phenolic compounds using LC‐ESI‐MS/MS. It resulted in tentative identification of 12 polyphenols (4‐hydroxy benzoic acid, umbelliferone, caffeic acid, quinic acid, pinocembrin, esculin, chlorogenic acid, caffeic acid 3‐glucoside water adduct, caffeic acid 3‐glucoside, kaempferol 7‐ O ‐glucoside, luteolin 7‐ O ‐glucoside, and 3,5‐dicaffeoylquinic acid) based on MS 2 fragments. Molecular docking of the identified polyphenols showed their enzyme inhibitory potential. The IC 50 values of the tested fraction for lipoxygenase, acetylcholinesterase, urease, tyrosinase, and monoamine oxidase (MAO) A and B were 68.21 ± 1.06, 49.09 ± 1.63, 116.90 ± 0.72, 52.30 ± 0.15, 0.48 ± 0.03, and 2.23 ± 0.57 µg mL −1 , respectively. Based on current findings, we recommend the exploitation of the n ‐butanol fraction of P. candollei for use in biotherapeutic formulations.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.